Free Trial
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Drugs Made in America Acquisition logo
$10.58 0.00 (0.00%)
As of 07/31/2025

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Key Stats

Today's Range
$10.58
$10.58
50-Day Range
$10.25
$10.58
52-Week Range
$10.00
$10.82
Volume
N/A
Average Volume
40,929 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DMAAU Stock News Headlines

DMAAU Drugs Made In America Acquisition Corp. Units
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
DMAA Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition's stock was trading at $10.00 at the beginning of 2025. Since then, DMAAU shares have increased by 5.8% and is now trading at $10.58.

Drugs Made in America Acquisition (DMAAU) raised $200 million in an IPO on Tuesday, January 28th 2025. The company issued 20,000,000 shares at $10.00 per share. Clear Street served as the underwriter for the IPO.

Drugs Made in America Acquisition's lock-up period expired on Monday, July 28th. Drugs Made in America Acquisition had issued 20,000,000 shares in its public offering on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAAU
CIK
2028614
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners